|4Mar 13, 4:03 PM ET

Pilo Shlomo 4

4 · Raphael Pharmaceutical Inc. · Filed Mar 13, 2023

Insider Transaction Report

Form 4
Period: 2022-12-05
Pilo Shlomo
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Warrants to Purchase Common Stock

    2022-12-05+1,000,0001,000,000 total
    Exercise: $1.12Exp: 2025-12-31Common Stock (1,000,000 underlying)
Footnotes (1)
  • [F1]The warrants are exercisable immediately.

Documents

1 file
  • 4
    ownership.xmlPrimary